Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast
- 1 October 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (7) , 1005-1011
- https://doi.org/10.1038/bjc.1996.481
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptorsInternational Journal of Cancer, 1994
- Expression of the pS2 gene in normal, benign and neoplastic human stomachInternational Journal of Cancer, 1989
- Immunocytochemical identification of cell types in human mammary gland: variations in cellular markers are dependent on glandular topography and differentiation.Journal of Histochemistry & Cytochemistry, 1989
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breastMolecular and Cellular Probes, 1989
- Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancerInternational Journal of Cancer, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970